Phase Iv Trials
Phase IV Trials is a type of clinical trial conducted after a pediatric medical intervention has been approved for public use, specifically designed to monitor long-term safety, effectiveness, and rare adverse effects in diverse pediatric populations under real-world conditions.
523
Publications
19.2K
Citations
4.2K
Authors
1.9K
Institutions
Publications per year
2017–2026
232
Parents
523
Salim Yusuf, Robert T. Collins, Richard Peto et al. · European Heart Journal · 1985 · 572 citations
Medicine, Cardiology, Pharmacology +15
Qian Chen, Chang Shu, Arian Laurence et al. · Gut · 2018 · 258 citations · Full text
Medicine, Oncology, Pharmacology +13
1–5 of 523
4.2K
4
h-index
4
h-index
4
h-index
4
h-index
University of Tennessee Health Science Center, United States
4 publications · 70 citations
4
h-index
1–5 of 4.2K
1.9K

Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
13 h-index
66 publications
1.7K citations
Novartis (Switzerland)
Basel, Switzerland
12 h-index
21 publications
1K citations

Brigham and Women's Hospital
Boston, United States
12 h-index
23 publications
2.7K citations
Asan Medical Center
Seoul, South Korea
11 h-index
21 publications
428 citations

University of Ulsan
Ulsan, South Korea
11 h-index
15 publications
297 citations

Sun Yat-sen University
Guangzhou, China
11 h-index
11 publications
598 citations
Sanofi (France)
Paris, France
11 h-index
26 publications
902 citations

University of Toronto
Toronto, Canada
11 h-index
13 publications
513 citations
1–8 of 1.9K
Repository · 33 publications · 911 citations
17
h-index
11 publications · 223 citations
10
h-index
13 publications · 316 citations
10
h-index
9 publications · 252 citations
9
h-index
8 publications · 428 citations
8
h-index
1–5